STUDresearch · Peptide
GLOW stack
Also known as
Glow blend · GLOW peptide · GHK-Cu + BPC-157 + TB-500 · glow stack 70mg · GLOW 5:1:1 · 50/10/10 blend · GHK BPC TB blend · Glow 70 · GLOW 50 · GLOW 70 · 5:1:1 blend
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Peptide
Lots of talk
Mixed
SubQ
Healing stacks (named blends)
Mixed — BPC may be near the complaint; TB and GHK are treated as whole-body.
What people say
GLOW is a vendor/community name for a fixed-ratio GHK-Cu, BPC-157 and TB-500 blend, not one molecule. The common 50/10/10 mg vial is not universal.
Doses people talk about
These are descriptive self-reports and vendor/community charts. The fixed mixture has no validated human dose progression, and formulations are not interchangeable.
How it may feel
Reports conflict across blend, dose, co-treatment and goal. One 50/10/10 diary described joint and gut improvement plus nausea and dizziness near week 2, later mostly resolving; another three-month user reported recovery and skin benefit, while others report no effect, sting, itch or rash.
Inspected 50/10/10 diary0.625/0.125/0.125 mg, then 1.25/0.25/0.25 mg, then 1.875/0.375/0.375 mg GHK-Cu/BPC-157/TB-500
Same-author daily-to-weekday sequence across roughly two weeks before nausea and dizziness, later mostly resolved after a split-day change. Descriptive adverse chronology, not an instruction.
Inspected three-month blend account1–2 mg GHK-Cu + 250 mcg BPC-157 + 250 mcg TB-500
One uncontrolled report attributed recovery and skin changes to this mixed daily blend and reported no injection pain; other users in the thread differed.
Common 50/10/10 chart~1.5–2 mg GHK-Cu + ~0.3–0.4 mg BPC-157 + ~0.3–0.4 mg TB-500
Daily community-chart amounts for a true 5:1:1 vial, not a clinical fixed-blend dose.
Separate-component cultureBPC-157 250–500 mcg/day; GHK-Cu 1–2 mg/day; TB-500 2–2.5 mg per administration
Legacy separate-vial ranges use different calendars, especially for TB-500, and should not be treated as equivalent to a daily pre-blend.
Half-life & effect duration
- Half-life in the body
- Whole blendNo single half-life
- GHK-Cu component · community estimateTens of minutes to about 1 hour
- Felt duration people report
- Early / continued reportsRecovery claims, later skin changes, or no effect
- Other experiencesInjection reactions, nausea or dizziness; one diary describes nausea and dizziness around week 2
Cycles people discuss
Forum and seller blocks range from about four weeks to 8–12 weeks, with conflicting break patterns. No controlled study establishes a fixed-blend cycle or long-term repeated-cycle safety.
Timing
Morning once-daily SubQ appears in GLOW charts, while other users prefer evenings. Consistency and whether injection sting disrupts sleep drive the timing discussion; overnight-repair rationales remain community claims, not a proven timing advantage.
Stacks
GLOW is already a three-part stack. KLOW adds KPV; Wolverine drops GHK-Cu. Adding more recovery compounds further weakens attribution.
Access talk
Three buy identities: RUO pre-mix vials, clinic “GLOW stack” kits, and separate compounded components. The Instagram name is not a COA.
Labs people mention
Copper / zinc chatter: Long GHK-heavy GLOW runs get “check copper and don’t ignore zinc” posts — 3-month labs in some logs, not a blend trial requirement.
Watch for
Long-term safety: Long-term human safety of repeated GLOW cycling is not established; sparse blend-specific data.
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
No reviewed human study establishes one pharmacokinetic clock for the fixed triple blend.
The inspected material consists of individual community accounts. Component identity, dose ratio and scheduling vary, and no validated assay followed all three parents together.
Do not infer a blend half-life from a component, injection interval, reported benefit window or vendor chart.
- GLOW effects — same-author dose and symptom diary (opens in a new tab)Original post and same-author updates/replies: identifies a 50/10/10 blend; reports 0.625/0.125/0.125 mg daily for three days, then 1.25/0.25/0.25 mg daily, then 1.875/0.375/0.375 mg Monday–Friday; nausea/dizziness began near the end of week 2, with later report of mostly resolving after split-day use and ongoing joint/gut benefit.One changing-dose, uncontrolled diary with self-selected timing and no blinded rechallenge, laboratory confirmation or product assay. The reported split is descriptive, not a recommendation.
- GHK-Cu 27 mg / BPC-157 5 mg / TB-500 10 mg experience thread (opens in a new tab)Complete post and replies, including one roughly three-month account describing 1–2 mg GHK-Cu plus 250 mcg BPC-157 and 250 mcg TB-500, perceived recovery/skin effects and no injection pain; other participants report different or absent effects.Uncontrolled multi-peptide reports with variable blends, goals and co-interventions; product identity and actual concentration were not independently tested.
Felt duration people report
Reports range from no noticeable effect to early recovery claims, later skin changes, injection reactions, nausea and dizziness.
One 50/10/10 diary linked nausea and dizziness to the end of week 2 and later said they mostly resolved after a split-day change. Another three-month account claimed recovery and skin benefit; other posters reported null effects or local reactions.
Uncontrolled reports, changing exposure, ratio uncertainty, concurrent recovery changes and self-attribution prevent a reliable felt window or component assignment.
- GLOW effects — same-author dose and symptom diary (opens in a new tab)Original post and same-author updates/replies: identifies a 50/10/10 blend; reports 0.625/0.125/0.125 mg daily for three days, then 1.25/0.25/0.25 mg daily, then 1.875/0.375/0.375 mg Monday–Friday; nausea/dizziness began near the end of week 2, with later report of mostly resolving after split-day use and ongoing joint/gut benefit.One changing-dose, uncontrolled diary with self-selected timing and no blinded rechallenge, laboratory confirmation or product assay. The reported split is descriptive, not a recommendation.
- GHK-Cu 27 mg / BPC-157 5 mg / TB-500 10 mg experience thread (opens in a new tab)Complete post and replies, including one roughly three-month account describing 1–2 mg GHK-Cu plus 250 mcg BPC-157 and 250 mcg TB-500, perceived recovery/skin effects and no injection pain; other participants report different or absent effects.Uncontrolled multi-peptide reports with variable blends, goals and co-interventions; product identity and actual concentration were not independently tested.
- GLOW side effects — rash discussion (opens in a new tab)Original post and visible replies describing sting, itch or rash during GLOW use; mechanistic explanations and suggested fixes were treated as unverified discussion rather than facts.Self-reported products and symptoms, no dermatologic diagnosis or causality assessment, and replies include unsupported mechanistic claims.
What people say
- Soft-tissue / injury: Same BPC+TB “tendon, ligament, strain bounce-back” anecdotes as Wolverine culture — confounded by rest, PT, and deload. forumanecdote
- Skin quality / “glow”: GHK-Cu portion gets credit for tone, firmness, hydration feel, recovery look in photos — lighting and skincare confound heavily. forumanecdote
- Collagen / ECM narrative: Copper-peptide story (lysyl oxidase / collagen I–III crosslink talk) is the aesthetic marketing spine. forum
- Wound / scar / post-procedure: Med-spa and self-experiment threads for healing after aesthetic treatments or minor injuries. forum
- Hair adjacency: Some GHK threads spill into scalp/hair quality talk; slower timeline claims than skin. forumanecdote
- Aesthetic + gym crossover: Popular in “heal and look better” content (injury + face/skin same cycle). forum
- Inflammation noise: Users sometimes report less systemic “irritation noise” or faster bruise/tweak quieting — hard to attribute to which peptide. anecdote
- What people do not reliably claim: Instant skin transformation in week 1; guaranteed tendon heal; hair regrowth like a drug. Sparse/variable when honest. forum
- Aesthetic + gym crossover: Loud in “heal the joint and look better in photos” content — lighting and skincare confound the GHK “glow” half. forum
- 2025–26 pick vs KLOW: GLOW when the job is repair/skin/collagen and inflammation is not the pitch; KLOW when gut/flare/reactive-skin is why people pay the fourth peptide. No head-to-head trial of the blends. forum
- KPV is not in this vial. Gut-calm logs belong on KLOW or separate KPV — not “more GLOW units.” forum
Doses people talk about
- Common daily pre-blend targets (community charts): roughly ~1.5–2 mg GHK-Cu with ~0.3–0.4 mg BPC-157 and ~0.3–0.4 mg TB-500 in the same pin, once daily. Example shorthand people use for a true 50/10/10 draw: ~1.7/0.3/0.3 mg (GHK/BPC/TB). forum
- What people buy (most-cited pre-blend): 50 mg GHK-Cu + 10 mg BPC-157 + 10 mg TB-500 per vial (often called 50/10/10 or 5:1:1, ~70 mg total). Other sizes exist — do not assume. forum
- How to read blend doses: Talk in per-peptide amounts (e.g. ~1.5–2 mg GHK-Cu / ~0.3–0.4 mg BPC / ~0.3–0.4 mg TB), not one “total mg of all three” number. A single “2.3 mg GLOW” figure hides that most of the mass is GHK-Cu. forum
- Slightly higher GHK-anchored talk: Some logs aim ~2 mg GHK-Cu first → on a real 50/10/10 mix that lands near ~2 / 0.4 / 0.4 mg (GHK/BPC/TB) per day. forum
- Forum example (DIY 50/10/10 lore): One widely quoted personal log targets about 1.5 mg GHK-Cu + 0.3 mg BPC + 0.3 mg TB daily (not a trial). forum
- If run as separate vials (not pre-mixed): BPC-157 ~250–500 mcg/day; GHK-Cu ~1–2 mg/day; TB-500 more often ~2–2.5 mg 2×/week load, then ~2–2.5 mg 1×/week maintain — different calendar than daily micro-TB from a pre-blend. forum
- Schedule culture: Pre-blend charts are usually once daily subq. Some use 5 days on / 2 off; GHK-focused posters often prefer 7 days/week during a skin block. forum
- Why pre-blend ≠ classic TB: Daily blend draws give hundreds of mcg TB/day, not multi-mg 2×/week TB charts — convenience tradeoff, not “same as Wolverine dosing.” forum
- GLOW 50 / 42 mg-class: ~27–35 mg GHK + 5–10 mg BPC/TB is a different ratio. Copying a 50/10/10 unit chart onto that vial overshoots TB or undershoots GHK. Read the three numbers. forum
- DIY unbundle ratios: Separate-vial people sometimes run higher BPC/TB (50/20/30 talk shows up) because the pre-mix is copper-dominant. Preference, not a trial. forum
- Framing: Community/vendor talk only — not medical advice, not a clinical protocol. Always read your vial’s mg of each peptide; “GLOW” is a nickname, not a regulated formula. forum
How it may feel
- Days 1–3: Mostly logistics — pin technique, site sting (especially GHK-Cu copper/histamine talk), little systemic “feel.” Some note early inflammation quieting; also placebo-heavy window. forumanecdote
- Week 1: Injury noise may start shifting for acute tweaks; skin usually not yet “different.” Old-injury “flare” anecdotes sometimes blamed on TB restarting remodeling. forumanecdote
- Weeks 2–4: Common checkpoint for soft-tissue anecdotes and early “skin feels different / more hydrated” reports. In one 50/10/10 GLOW diary, nausea and dizziness began near the end of week 2 after stepped-up weekday use; the same author later said symptoms mostly resolved after splitting the day’s amount, while joint and gut improvements continued. This is one confounded self-report, not a schedule recommendation. forum
- Weeks 4–6+: Aesthetic/collagen talk often framed as needing consistent daily GHK for several weeks before photo-worthy claims; some community voices argue ≥6 weeks daily for collagen impact vs 4-week vendor charts. forum
- Weeks 4–8 (block end): Typical end of many injury-oriented blend blocks; reassess load and goals. forum
- Rest / off weeks: Structural skin/injury changes may hold briefly; many report plateau then partial return of symptoms with load or skin habits. anecdote
- Multi-cycle: Skin/anti-aging content often describes multiple cycles over months; diminishing returns and confounds (skincare, sleep, weight) are common. forum
- Attribution problem: Three peptides in one pin → hard to know which “worked”; separate vials make isolation easier. forum
- Copper uglies (weeks ~2–5 if they hit): Forum name for dry/flaky, breakouts, dull/grey cast, or “wrinkles look deeper” on GHK-heavy GLOW. Not a published diagnosis. Some never get it. forum
- Uglies vs dose math: 2026 GLOW/KLOW wrecked-skin threads often traced to >2 mg GHK/day from counting total-blend units. Lower-copper camp says wait 4–8 weeks or drop the draw — not add tret. forum
Around the dose
- Clock: Daily morning SubQ is the common Glow habit, same as KLOW without the KPV. forum
- Training: Not a pump shot. Pin at home, train later — GHK sting plus gym sweat is a regular complaint. forum
- Habits: Protein, sleep, and not torching the same tendon twice a week get mentioned when a Glow log looks good. forum
- Skin days: Collagen/“glow” talk wants consistency more than a heroic Saturday dose. forum
- vs KLOW: Drop KPV if gut/inflammation isn’t the job. Don’t run both blends. forum
- Dose off GHK-Cu, not “mg of GLOW.” 2025–26 visual guides: ~1.7–2 mg copper is the number people compare; BPC/TB ride along. forum
- Copper-uglies weeks: Skip stacking tret/acids/needling on the face the same weeks the skin is flaking. Zinc talk shows up next to sting — not a proven fix. forum
- Night vs morning: Sting that wrecks sleep is why people move the pin to morning; others want overnight repair and accept the ache. No PK winner. forum
Cycles people discuss
- Most-repeated vendor chart: ~4 weeks on, then 2–4 weeks off (often framed as ~one vial month for daily 50/10/10 draws). forum
- Repair / aesthetic blocks: ~6–8 weeks on appears often; some skin protocols stretch 8–12 weeks then off. forum
- GHK-consistency camp: Some community voices want ≥~6 weeks daily for collagen/skin talk, then a multi-week break — conflicts with short 4-week sales charts. forum
- Injury re-runs: Multiple cycles/year when training load returns; long-term multi-year safety of the triple is not established. forum
- Stop / reassess: Budget, GHK site sting, goal met, or no meaningful change by ~4 weeks → reassess load/diagnosis, not only “more blend.” forum
- Uglies vs 4-week sales chart: Skin-purge talk often peaks inside the first vendor “one vial month,” which is why people quit before the 6–8 week collagen window. forum
Timing
- No public PK for the three mixed in one syringe: Community timing is component lore stitched together, not blend pharmacokinetics. forum
- GHK-Cu half-life talk: Often described as very short (tens of minutes to ~1 hour range in informal discussion) → daily (or more frequent) consistency culture for skin goals. forum
- BPC half-life talk: Short systemic half-life discussion → daily (sometimes 2×/day when separate). forum
- TB-500 / TB-4 fragment talk: Longer “repair window” / multi-day narrative → classic less-than-daily or 2× weekly patterns when run solo; blend ignores that and pins daily. forum
- Why daily blend dominates: Matches BPC + GHK habits more than TB’s traditional schedule. forum
- 5 on / 2 off debate: Some charts allow weekend offs; GHK-focused posters often say skipping days wastes short-HL GHK and prefer no mid-week breaks during a skin block. forum
- Downstream remodeling vs blood levels: Users distinguish “still in blood” from “tissue still remodeling during off weeks.” anecdote
- Timing of day: Morning vs evening usually “pick a time you can repeat”; not a settled PK requirement. forum
- KPV timing does not apply here. GLOW has no KPV. Splitting KPV AM / GHK PM is a KLOW-unbundle move, not a GLOW chart. forum
More on what it is
- X/marketing shorthand: People search “GLOW peptide / GLOW 70” before learning GHK-Cu + BPC + TB names — convenience blend culture is the product. forum
- What it is: Named triple peptide stack/blend of GHK-Cu + BPC-157 + TB-500 (TB-500 often labeled as TB-4 fragment depending on vendor). Not a single molecule. forum
- Composition table (most-cited 70 mg vial): 50 mg GHK-Cu + 10 mg BPC-157 + 10 mg TB-500 → 5:1:1, ~70 mg total active. forum
- Ratio callout: “5:1:1” and “50/10/10” are the dominant retail labels — not universal; some 42 mg / lower-copper vials exist (e.g. ~27–30 mg GHK with smaller BPC/TB). forum
- vs Wolverine: Wolverine = BPC + TB only (injury/repair focus). GLOW = same core + GHK-Cu. forum
- vs KLOW: KLOW = GLOW base + KPV (often marketed as ~80 mg: 50/10/10/10). KPV is the gut/inflammation differentiator. forum
- Search reality: Many people hit “GLOW peptide / glow 70mg” before learning the three component names. forum
- Evidence honesty: Named blend is clinic/vendor/forum culture; no robust human RCT of the fixed triple mix. Component literature is animal/topical/community for each peptide separately. trialforum
- What most people mean: GLOW = GHK-Cu + BPC-157 + TB-500 pre-blend (ratios vary); Wolverine is usually BPC+TB only; KLOW adds KPV. forum
- What you are buying: Usually a pre-mixed multi-peptide vial, not one molecule. Ratios vary by vendor. forum
- GLOW 70 vs GLOW 50 (2025–26 label fight): “70” usually means 50/10/10 (~70 mg total), not 70 mg of GHK. “GLOW 50” / 42 mg-class vials (~27–35 mg GHK + smaller BPC/TB) under-dose copper vs the Anela-style 50/10/10 charts. forum
- Mass share on 50/10/10: GHK-Cu is ~71% of every draw. A “2.3 mg GLOW” line is mostly copper. forum
- Not the spa drip: Med-spa “Glow IV” is usually glutathione + vitamin C (± GHK). Same word, different product. forum
- Why “GLOW”: Marketing shorthand for repair peptides (Wolverine core) plus copper peptide for skin/collagen/“glow” aesthetic framing. forum
- Research-only framing: Research-chem and compounding talk ≠ approved combo drug. forum
- July 2026 PCAC is not a GLOW vote: BPC-157 and TB-500 got advisory 503A recommendations (reported 8–6–1). GHK-Cu was not on that seven-peptide panel. The pre-mix itself was never voted. trial
Stacks
- Standalone GLOW: The triple is already a named stack — many run it alone for 4–8 weeks. forum
- → KLOW: Add KPV (or buy 80 mg quad blend) when gut/inflammation narrative is the goal. forum
- ← Wolverine: Drop GHK-Cu for pure injury focus or if copper/site reactions are intolerable. forum
- GH secretagogues: Sometimes layered with CJC-1295 / Ipamorelin, sermorelin, or sleep-recovery lifestyle stacks — multiplies cost and unknowns. forum
- PT / load management: Honest threads treat training deload and physical therapy as co-interventions, not optional. forum
- Topical GHK + injectable blend: Some run topical copper peptides for face while injecting GLOW — double-counting GHK exposure talk. forum
- Avoid blind mega-stacks: Forums warn against piling more injectables (extra healing peptides, “kitchen sink”) without a reason. forum
- GLOW 70 + extra BPC/TB: 2026 “fighting the ratios” move when the pre-mix undershoots injury charts. Attribution gets messier. forum
Access talk
- Three buy identities: RUO pre-mix vials, clinic “GLOW stack” kits, and separate compounded components. The Instagram name is not a COA. forum
- Glow drip ≠ Glow vial. Glutathione/vitamin-C spa IVs are a different SKU that hijacks the search term. forum
- RUO still the loud path: A committee vote on two of three ingredients did not turn research-chem blends into pharmacies. forum
- Not a listed drug and not a PCAC blend. July 23, 2026 PCAC recommended BPC-157 and TB-500 (reported 8–6–1) for the 503A bulks list. Advisory only — not a finished listing, not an approval of “GLOW.” trial
- GHK-Cu missed that panel. Injectable GHK-Cu nomination was withdrawn; non-injectable GHK-Cu went back to 503A Category 1 in the May 14, 2026 FDA reference update, with PCAC talk before end of February 2027. trial
Labs people mention
- Copper / zinc chatter: Long GHK-heavy GLOW runs get “check copper and don’t ignore zinc” posts — 3-month labs in some logs, not a blend trial requirement. forum
- No GLOW panel: People are not watching a peptide level. Skin photos and tendon noise are the logs. forum
Storage notes
- No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
- Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum
Watch for
- Injection-site sting/burn: Extremely common with GHK-Cu — copper/pH/osmolality/mast-cell-histamine lore; some report severe enough sting that they abandon GHK or the whole blend. forumanecdote
- Redness, itch, welt, bruise: Local reactions; copper-related irritation reports more than plain BPC/TB alone. forum
- GHK “uglies” / skin quirks: Temporary dryness, breakout/flare, sensitivity talk in copper-peptide circles. forumanecdote
- Systemic mild reports: Transient fatigue, headache, nausea, metallic taste at higher copper loads — infrequent but discussed. forum
- Ratio lock-in: Pre-blend cannot raise BPC for a tendon goal without also raising GHK/TB; cannot drop GHK if sites hate copper. Separate vials fix that. forum
- TB schedule mismatch: Daily low-dose TB in blend ≠ classic weekly TB loading — may under- or over-serve TB goals depending on math. forum
- Purity / identity risk: Three APIs in one cake → harder third-party verification; underfill and mislabel risk multiplies vs single-peptide vials. forum
- Angiogenesis / cancer caution talk: All three have growth/repair narratives; active cancer is a hard stop in community risk discussions (theoretical, not blend-trial proven). forum
- WADA / tested athletes: TB-500 / thymosin-related substances appear on anti-doping radar — competitive athletes treat as prohibited risk. forum
- Pregnancy / breastfeeding: No safety data; community lists as avoid. forum
- Not magic skin drug: Photos, filters, lighting, retinoids, and weight change confound aesthetic claims. anecdote
- Cost stacking: Daily multi-mg GHK share drives spend; “one more cycle” adds up fast. forum
- Legal / labeling: Many sellers still “research use only”; compounding legality varies by jurisdiction and year. forum
- Long-term safety: Long-term human safety of repeated GLOW cycling is not established; sparse blend-specific data. trialforum
- GHK-Cu sting: Copper peptide portion often blamed for more site burn/itch than BPC alone. forum
- Copper uglies are internet lore, not a paper. 2026 threads still treat dryness/breakouts/deeper lines as a GHK purge; skeptics note zero named studies. Both posts exist. forum
- Math error → 4–5 mg GHK: Counting 15–20 units of a 3 mL 70/80 mg vial as “the dose” is a recurring ugly-skin post. forum
Evidence mix
Mostly community / anecdote tags
Full: every bullet (trial + community). Use Scan for a faster bro-science read.